The Differential Expression of Cide Family Members is Associated with Nafld Progression from Steatosis to Steatohepatitis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The Differential Expression of Cide Family Members is Associated with Nafld Progression from Steatosis to Steatohepatitis ; volume:9 ; number:1 ; day:16 ; month:5 ; year:2019 ; pages:1-12 ; date:12.2019
Scientific reports ; 9, Heft 1 (16.5.2019), 1-12, 12.2019
- Creator
-
Sans, Arnaud
Bonnafous, Stéphanie
Rousseau, Déborah
Patouraux, Stéphanie
Canivet, Clémence M.
Leclere, Pierre S.
Tran-Van-Nhieu, Jeanne
Luci, Carmelo
Bailly-Maitre, Béatrice
Xu, Xu
Lee, Ann-Hwee
Minehira, Kaori
Anty, Rodolphe
Tran, Albert
Iannelli, Antonio
Gual, Philippe
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-43928-7
- URN
-
urn:nbn:de:101:1-2019102403493109398307
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sans, Arnaud
- Bonnafous, Stéphanie
- Rousseau, Déborah
- Patouraux, Stéphanie
- Canivet, Clémence M.
- Leclere, Pierre S.
- Tran-Van-Nhieu, Jeanne
- Luci, Carmelo
- Bailly-Maitre, Béatrice
- Xu, Xu
- Lee, Ann-Hwee
- Minehira, Kaori
- Anty, Rodolphe
- Tran, Albert
- Iannelli, Antonio
- Gual, Philippe
- SpringerLink (Online service)
Other Objects (12)
Analyse von immunohistologischen Faktoren in der Progression von nicht-alkoholischer Steatosis hepatis zur Steatohepatitis
Imaging-Based Assessment of Steatosis, Inflammation and Fibrosis in NAFLD
Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis
Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD
Construction of SteatoNet : a metabolic network to investigate NAFLD-related hepatic steatosis
Treatment with Oxidized Phospholipids Directly Inhibits Nonalcoholic Steatohepatitis and Liver Fibrosis Without Affecting Steatosis
Hepatic steatosis and steatohepatitis: a functional meta-analysis of sex-based differences in transcriptomic studies
HADHA alleviates hepatic steatosis and oxidative stress in NAFLD via inactivation of the MKK3/MAPK pathway
Validity of routine biochemical and ultrasound scores for prediction of hepatic fibrosis and steatosis in NAFLD
New Avenues for Treatment and Prevention of Drug-Induced Steatosis and Steatohepatitis: Much More Than Antioxidants
β-Hydroxyphosphocarnitine modifies fibrosis, steatosis and improves liver function in non-alcoholic steatohepatitis induced in rats
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Analyse von immunohistologischen Faktoren in der Progression von nicht-alkoholischer Steatosis hepatis zur Steatohepatitis
Imaging-Based Assessment of Steatosis, Inflammation and Fibrosis in NAFLD
Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis
Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD
Construction of SteatoNet : a metabolic network to investigate NAFLD-related hepatic steatosis
Treatment with Oxidized Phospholipids Directly Inhibits Nonalcoholic Steatohepatitis and Liver Fibrosis Without Affecting Steatosis
Hepatic steatosis and steatohepatitis: a functional meta-analysis of sex-based differences in transcriptomic studies
HADHA alleviates hepatic steatosis and oxidative stress in NAFLD via inactivation of the MKK3/MAPK pathway
Validity of routine biochemical and ultrasound scores for prediction of hepatic fibrosis and steatosis in NAFLD
New Avenues for Treatment and Prevention of Drug-Induced Steatosis and Steatohepatitis: Much More Than Antioxidants
β-Hydroxyphosphocarnitine modifies fibrosis, steatosis and improves liver function in non-alcoholic steatohepatitis induced in rats
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Analyse von immunohistologischen Faktoren in der Progression von nicht-alkoholischer Steatosis hepatis zur Steatohepatitis
Imaging-Based Assessment of Steatosis, Inflammation and Fibrosis in NAFLD
Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis
Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD
Construction of SteatoNet : a metabolic network to investigate NAFLD-related hepatic steatosis
Treatment with Oxidized Phospholipids Directly Inhibits Nonalcoholic Steatohepatitis and Liver Fibrosis Without Affecting Steatosis
Hepatic steatosis and steatohepatitis: a functional meta-analysis of sex-based differences in transcriptomic studies
HADHA alleviates hepatic steatosis and oxidative stress in NAFLD via inactivation of the MKK3/MAPK pathway
Validity of routine biochemical and ultrasound scores for prediction of hepatic fibrosis and steatosis in NAFLD
New Avenues for Treatment and Prevention of Drug-Induced Steatosis and Steatohepatitis: Much More Than Antioxidants
β-Hydroxyphosphocarnitine modifies fibrosis, steatosis and improves liver function in non-alcoholic steatohepatitis induced in rats